Atrial Fibrillation New Onset
Conditions
Brief summary
This is a randomized controlled trial (RCT) to test a novel artificial intelligence (AI)-enabled electrocardiogram (ECG)-based screening tool for improving the diagnosis and management of Atrial Fibrillation.
Interventions
Primary care clinicians in the intervention group had access to the report, which displayed whether the AI-ECG result was positive or negative. The system will send a message to corresponding physicians if positive finding.
Sponsors
National Defense Medical Center, Taiwan
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SCREENING
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients in emergency department or inpatient department * Patients had at least 1 ECG * Patients cared by non-cardiologist
Exclusion criteria
* Patients without history of atrial fibrillation diagnosis. * Patients without history of long-term NOAC or warfarin usage. * Patients without history of hemorrhagic stoke or ishemic stroke. * Patients with low eGFR (\<30 ml/min)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Proportion of ischemic Stroke | Within 90 days | After performing an electrocardiogram, the patient's physical conditions is tracked. |
| Proportion of taking AF treatment medications | Within 90 days | defined as use of long-term NOAC (apixaban, rivaroxaban, endoxaban, dabigatran). |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Proportion of echocardiogram performed after ECGs | Within 90 days | After performing the ECG examination, perform the echocardiography examination. |
| Proportion of new-onset heart failure | Within 90 days | After performing an electrocardiogram, the patient's medical record is tracked. |
| Proportion of cardiologist consultation | Within 90 days | Cardiovascular outpatient visit after discovering atrial fibrillation. |
| Proportion of hemorrhagic stroke | Within 90 days | After performing an electrocardiogram, the patient's medical record is tracked. |
| Proportion of all cause mortality(death) | Within 90 days | After performing an electrocardiogram, the patient's survival is tracked. |
| Proportion of gastrointestinal bleeding | Within 90 days | After performing an electrocardiogram, the patient's medical record is tracked. |
| Proportion of new-onset AF diagnosis | Within 90 days | Atrial fibrillation diagnosis in medical records |
Countries
Taiwan
Outcome results
None listed